Southpoint Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cars.com
CARS
|
+$57.5M |
| 2 |
Fennec Pharmaceuticals
FENC
|
+$46.4M |
| 3 |
Sanofi
SNY
|
+$38.7M |
| 4 |
Comcast
CMCSA
|
+$19.7M |
| 5 |
8x8 Inc
EGHT
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$74.5M |
| 2 |
Northern Trust
NTRS
|
+$68M |
| 3 |
Elevance Health
ELV
|
+$66.6M |
| 4 |
Johnson Controls International
JCI
|
+$60.7M |
| 5 |
Synchrony
SYF
|
+$46.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.76% |
| 2 | Communication Services | 17.01% |
| 3 | Financials | 15.07% |
| 4 | Industrials | 12.55% |
| 5 | Healthcare | 9.17% |
Similar funds
Southpoint Capital Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, Southpoint Capital Advisors held 42 positions worth $2.44B, down 3.9% from $2.53B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Southpoint Capital Advisors withdrew a net $285M in Q3 2017, closing 6 positions and reducing 14 holdings. Its most notable exit was Northern Trust, an estimated $68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Southpoint Capital Advisors opened a new position in Fennec Pharmaceuticals worth $44.3M.
- Southpoint Capital Advisors's largest Q3 2017 buy was Fennec Pharmaceuticals: 3,997,214 shares worth $44.3M.
- Southpoint Capital Advisors added most to Cars.com in Q3 2017, an estimated $57.5M increase.
- Southpoint Capital Advisors's biggest Q3 2017 reduction was FedEx, cutting an estimated $74.5M.
- Southpoint Capital Advisors fully exited Northern Trust in Q3 2017, selling an estimated $68M.
- Southpoint Capital Advisors's ten largest holdings make up 55% of its $2.44B portfolio in Q3 2017.
- Southpoint Capital Advisors opened 2 new positions and closed 6 in Q3 2017.
- Southpoint Capital Advisors's portfolio value fell 3.9% quarter-over-quarter to $2.44B.
Based on Southpoint Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.